Clinical trial Recruiting at 1 site Observational Ages 20 and up

Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography

Official title: A Prospective Observational Study to Develop and Validate a Multimodal Deep Learning Model Integrating Peripheral Oxygen Saturation and Ballistocardiography Signals for the Prediction of Apnea-Hypopnea Index in Patients With Suspected Obstructive Sleep Apnea

Run by Fu Jen Catholic University · NCT07923825 · Data updated 2026-11-12

Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment100 (estimated)
SponsorFu Jen Catholic University
Academic / other
Locations1 site (New Taipei City, New Taipei City)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedNovember 6, 2026
Trial IDNCT07923825 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20 years or older referred for in-lab PSG due to suspected OSA who can provide informed consent.

Probably not a fit

Individuals without suspected OSA or with sleep disorders other than OSA may not benefit from this model for AHI estimation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study develops and validates a multimodal deep learning model that combines peripheral oxygen saturation and ballistocardiography signals collected from a smart mattress to estimate the apnea-hypopnea index. Adult participants referred for in-lab polysomnography with suspected obstructive sleep apnea will have synchronized SpO2 and BCG data recorded during sleep. The model’s predicted AHI will be compared with PSG-derived AHI using predefined metrics, with secondary analyses on OSA severity discrimination and signal feature associations. Data will be de-identified, and no changes to standard clinical care will be made. The study is led by Fu Jen Catholic University and conducted at its hospital site.

Why it matters

Potential benefit: If successful, this approach could enable non-invasive, convenient home-like screening or supplementary assessment to estimate OSA severity.

How similar studies have gone: Previous work has shown promise with single-modality signals; this study is exploring a multimodal approach, which is still relatively novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 20 years or older.
* Individuals referred for in-laboratory polysomnography due to suspected obstructive sleep apnea.
* Able and willing to provide informed consent.

Exclusion Criteria:

* Inability to provide informed consent.
* Presence of conditions that may interfere with sleep signal acquisition, as determined by the investigator.
* Prior diagnosis of sleep disorders other than obstructive sleep apnea that could confound study results.

Where it's running

  • Fu Jen Catholic University Hospital
    New Taipei City, New Taipei City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.